Cinqair Archives - World Asthma Foundation

FDA Approves Teva’s Cinqair for the Treatment of Severe Asthma – Pharmaceutical Technology Magazine (press release) (blog)

FDA Approves Teva's Cinqair for the Treatment of Severe Asthma
Pharmaceutical Technology Magazine (press release) (blog)
FDA approved Teva Pharmaceutical's Cinqair (reslizumab) on March 23, 2016 for use with other asthma medicines for the maintenance treatment of severe asthma in patients 18 years and older. Cinqair is approved for patients who have a history of severe …
FDA Approves Teva's Asthma Drug Cinqair as Add-on TreatmentLung Disease News
Nucala and Cinqair for the Treatment of Severe AsthmaAbout – News & Issues

all 3 news articles »

Asthma Attacks Face Newly Approved Super Treatment 'Cinqair'
The Inquisitr
Asthma attacks have a new opponent. And from clinical reports, asthma treatment Cinqair may be quite the formidable remedy. Although, there are side effects. Humans need adequate air flows in order to function properly. Yet, asthma's objective goes …
FDA approves Cinqair to treat severe asthmaFDA.gov
FDA approves new drug Cinqair to be used against AsthmaTampa Bay Review
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
The Hoops News –MedPage Today
all 72 news articles »

Asthma Attack Faces Newly Approved Super Treatment 'Cinqair'
The Inquisitr
Asthma attacks have a new opponent. And from clinical reports, asthma treatment Cinqair may be quite the formidable remedy. Although, there are side effects. Humans need adequate air flows in order to function properly. Yet, asthma's objective goes …
FDA approves Cinqair to treat severe asthmaFDA.gov
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
Teva's Cinqair Approved for Severe AsthmaMedPage Today
The Hoops News –Pharmacy Today, American Pharmacists Association, pharmacist.com
all 70 news articles »

FDA Approves Cinqair To Treat Severe Asthma
Pharmacy Practice News
The FDA has approved reslizumab (Cinqair, Teva Pharmaceuticals) as an add-on maintenance treatment for patients aged 18 years and older with an eosinophilic phenotype asthma, who have a history of severe exacerbations despite receiving their current …
FDA approves reslizumab to treat severe asthmaPharmacy Today, American Pharmacists Association, pharmacist.com
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
Cinqair Receives FDA Approval As Treatment For Severe AsthmaTech Times
Healio –Globes
all 61 news articles »

FDA approves Cinqair to treat severe asthma
FDA.gov
The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of …
Reslizumab (Cinqair) Approved to Treat Severe AsthmaMedscape
FDA Approves Reslizumab for Adults With Severe AsthmaMedPage Today
FDA clears Teva's asthma med CinqairSeeking Alpha
Monthly Prescribing Reference (registration)
all 25 news articles »